Stamm WE. Chlamydia trachomatis infections of the adults. In: Holmes KK, Sparling PF, et al. (eds) Sexually transmitted diseases, 4th ed. New York, NY:McGraw Hill, 2008, chap. 32.
Everett KD, Bush RM and Andersen AA. Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms. Int J Syst Bacteriol 1999; 49:415–440
Sachse K, Bavoil PM, Kaltenboeck B, et al. Emendation of the family Chlamydiaceae: proposal of a single genus, Chlamydia, to include all currently recognized species. Syst Appl Microbiol 2015; 38: 99–103.
Quinn TC, Gaydos C, Shepherd M, et al. Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. JAMA 1996; 276:1737–1742.
Ресурсы и деятельность медицинских организаций дерматовенерологического профиля. заболеваемость инфекциями, передаваемыми половым путем, заразными кожными болезнями и заболеваниями кожи за 2017-2018 годы (статистические материалы). Москва. 2019. 208 с. РИО: ФГБУ «ЦНИИОИЗ» Минздрава России.
Кубанова А. А., Мелехина Л. Е., Кубанов А. А. Основные задачи развития дерматовенерологической помощи населению Российской Федерации на период до 2024 года. Результаты деятельности медицинских организаций по оказанию дерматовенерологической помощи населению Российской Федерации в 2017 году. Вестник дерматологии и венерологии. 2018;94(5):9–25. https://doi.org/10.25208/0042- 4609-2018-945-9-25
Кубанова А. А., Кубанов А. А., Мелехина Л. Е. Динамика изменений интенсивных показателей заболеваемости инфекций, передаваемым половым путем, в оценке эпидемиологического процесса и состояния здоровья населения Российской Федерации за 2006–2016 годы. Вестник дерматологии и венерологии. 2018;94(1):27- 37. https://doi.org/10.25208/0042-4609-2018-94-1-27-37
Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2010. http://www.cdc.gov/std/stats11/surv2011.pdf (2011, accessed 15 August 2015).
European Centre for Disease Prevention and Control. Chlamydia control in Europe: literature review, http://www.ecdc.europa.eu/en/publications/Publications/chlamydia- control-europe.pdf (2014, accessed 15 August 2015).
European Centre for Disease Prevention and Control. Chlamydia infection. Annual epidemiological report for 2017. https://www.ecdc.europa.eu/sites/default/files/documents/AER_for_2017-chlamydia- infection.pdf
Dielissen PW, Teunissen DAM and Lagro-Janssen ALM. Chlamydia prevalence in the general population: Is there a sex difference? A systematic review. BMC Infect Dis 2013; 13: 534.
Redmond SM, Alexander-Kisslig K, Woodhall SC, et al. Genital chlamydia prevalence in Europe and non European high income countries: systematic review and meta-analysis. PLoS One 2015; 10: e0115753.
Дерматология по Томасу Фицпатрику. Атлас-справочник. Фицпатрик Т., Джонсон Р., Вулф К., Полано М., Сюрмонд Д. WORD, 1248 стр., 2007 г.
Rees E. The treatment of pelvic inflammatory disease. Am J Obstet Gynecol 1980; 138: 1042–1047.
Adams EJ, Turner KME and Edmunds WJ. The cost effectiveness of opportunistic chlamydia screening in England. Sex Transm Infect 2007; 83: 267–274. discussion274 275.
van Valkengoed IG, Morre SA, van den Brule AJ, et al. Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes implications for cost-effectiveness analyses. Int J Epidemiol 2004; 33: 416–425.
Land JA, Van Bergen JEAM, Morre SA, et al. Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening. Hum Reprod Update 2010; 16: 189–204.
Oakeshott P, Kerry S and Aghaizu A. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ 2010; 340: c1642.
Kavanagh K, Wallace LA, Robertson C, et al. Estimation of the risk of tubal factor infertility associated with genital chlamydial infection in women: a statistical modelling study. Int J Epidemiol 2013; 42: 493–503.
Trent M, Bass D, Ness RB, et al. Recurrent PID, subsequent STI, and reproductive health outcomes: findings from the PID evaluation and clinical health (PEACH) study. Sex Transm Dis 2011; 38: 879–881.
Westrom L, Joesoef R, Reynolds G, et al. Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 1992; 19: 185–192.
Ness RB, Trautmann G, Richter HE, et al. Effectiveness of treatment strategies of some women with pelvic inflammatory disease: a randomized trial. Obstet Gynecol 2005;106: 573–580.
Ross J, Judlin P and Jensen J. 2012 European guideline for the management of pelvic inflammatory disease. Int J STD AIDS 2014; 25: 1–7.
Cusimano A, Abdelghany AM, Donadini A Chronic intermittent abdominal pain in young woman with intestinal malrotation, Fitz-Hugh-Curtis Syndrome and appendiceal neuroendocrine tumor: a rare case report and literature review. BMC Womens Health. 2016 Jan 16;16:3. doi: 10.1186/s12905-015-0274-2.
den Heijer CDJ, Hoebe CJPA, Driessen JHM et al. Chlamydia trachomatis and the Risk of Pelvic Inflammatory Disease, Ectopic Pregnancy, and Female Infertility: A Retrospective Cohort Study Among Primary Care Patients. Clin Infect Dis. 2019 Oct 15;69(9):1517- 1525. doi: 10.1093/cid/ciz429.
De Seta F, Banco R, Turrisi A et al. Pelvic inflammatory disease (PID) from Chlamydia trachomatis versus PID from Neisseria gonorrhea: from clinical suspicion to therapy. G Ital Dermatol Venereol. 2012 Oct;147(5):423-30.
Jaiyeoba O, Lazenby G, Soper DE. Recommendations and rationale for the treatment of pelvic inflammatory disease. Expert Rev Anti Infect Ther. 2011 Jan;9(1):61-70. doi: 0.1586/eri.10.156.